Research has shown that the adoptive transfer of FAP-CAR -T cells diminishes tumor growth in a FAP-dependent manner and can eliminate stromal cells, evident in several solid tumors, including mesothelioma, lung cancer, and pancreatic cancer, demonstrating antitumor activity in preclinical models (272, 290–292). The gene discussed is FAP; the disease is pancreatic neoplasm.